InsiderClue
← All stocks

Crinetics Pharmaceuticals, Inc.

CRNX Scheduled selling only
CIK 0001658247 #989 in the set updated 19 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$7.62M
$2.70M on a plan · $4.92M straight out of an exercise
Sold at will
$0.00
0 of 21 sales
Net
−$7.62M
$0.00 against sales at will

By person

15 insiders · 28 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Knight Jeff E.
Chief Dev. & Operating Officer
—
$3.79M (3) scheduled
−$3.79M
105,289
0.0993%
$4.21M
+100.2%
Struthers Richard Scott
President & CEO
—
$1.00M (3) scheduled
−$1.00M
111,100
0.1047%
$4.44M
−91.3%
Fust Matthew K
Director
—
$716.00K (1) scheduled
−$716.00K
0
0.0000%
$0.00
−100.0%
Pizzuti Dana
Chief Med and Dev Officer
—
$647.46K (4) scheduled
−$647.46K
66,837
0.0630%
$2.67M
+120.3%
Betz Stephen F.
Chief Scientific Officer
—
$396.61K (2) scheduled
−$396.61K
0
0.0000%
$0.00
−100.0%
Okey Stephanie
Director
—
$365.15K (3) scheduled
−$365.15K
0
0.0000%
$0.00
−100.0%
Vivaldi Coelho Rogerio
Director
—
$300.76K (3) scheduled
−$300.76K
0
0.0000%
$0.00
−100.0%
Schilke Tobin
Chief Financial & Infra. Ofcr.
—
$266.30K (1) scheduled
−$266.30K
0
0.0000%
$0.00
−100.0%
Kalofonos Isabel
Chief Commercial Officer
—
$137.50K (1) scheduled
−$137.50K
0
0.0000%
$0.00
−100.0%
WIERENGA WENDALL
Director
—
—
—
116,146
0.1095%
$4.65M
+6.3%
Wilson Marc
CFO
—
—
—
111,092
0.1047%
$4.44M
0.0%
WIERENGA WENDELL
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Deardorf Caren
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Nichols Weston
Director
—
—
—
0
0.0000%
$0.00
−100.0%
Bedrosian Camille L
Director
—
—
—
0
0.0000%
$0.00
−100.0%

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
Vivaldi Coelho Rogerio
2 Jul 2026
Director
Sold on a plan
3,000
$40.00
$120.00K
Okey Stephanie
17 Jun 2026
Director
Sold on a plan
608
$36.22
$22.02K
Okey Stephanie
17 Jun 2026
Director
Sold on a plan
6,292
$35.62
$224.12K
Struthers Richard Scott
16 Mar 2026
President & CEO
Sold on a plan
8,785
$37.77
$331.81K
Struthers Richard Scott
16 Mar 2026
President & CEO
Sold on a plan
13,196
$37.11
$489.70K
Betz Stephen F.
16 Mar 2026
Chief Scientific Officer
Sold on a plan
4,241
$37.77
$160.18K
Betz Stephen F.
16 Mar 2026
Chief Scientific Officer
Sold on a plan
6,371
$37.11
$236.43K
Knight Jeff E.
16 Mar 2026
Chief Operating Officer
Sold on a plan
3,961
$37.77
$149.61K
Knight Jeff E.
16 Mar 2026
Chief Operating Officer
Sold on a plan
5,950
$37.11
$220.80K
Vivaldi Coelho Rogerio
12 Mar 2026
Director
Sold on a plan
523
$36.77
$19.23K
Vivaldi Coelho Rogerio
12 Mar 2026
Director
Sold on a plan
4,477
$36.08
$161.53K
Schilke Tobin
3 Mar 2026
Chief Financial Officer
Sold on a plan
6,713
$39.67
$266.30K
Okey Stephanie
3 Mar 2026
Director
Sold on a plan
3,000
$39.67
$119.01K
Struthers Richard Scott
26 Sep 2025
President & CEO
Sold on a plan indirect
4,000
$45.00
$180.00K
Show all 28 transactions →

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 7
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 4,265,150
History held since 20 Jul 2018